ArticlePloS one2014

The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model.

Laure-Anne Van Bellinghen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.